Metraipolis › archive › dc_117f409e5098

Cost-effectiveness of the national dog rabies prevention and control program in Mexico, 1990-2015 — Europe PMC PMID:33661891

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/33661891
DOI
10.1371/journal.pntd.0009130
License (as archived)
CC0-1.0
Archived
2026-11-05T16:03:14.158Z
SHA-256 of the archived text
83187543d24a1294a8e4561c05ad8d45df046e81c682f0afd5c22d8c91f4c9cf
Stable URL of this page
https://metraipolis.com/documento/dc_117f409e5098

How to cite

Cost-effectiveness of the national dog rabies prevention and control program in Mexico, 1990-2015 — Europe PMC PMID:33661891 — Europe PMC (en), https://europepmc.org/article/MED/33661891 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_117f409e5098 (Metraipolis archive dc_117f409e5098, sha256 83187543d24a1294a8e4561c05ad8d45df046e81c682f0afd5c22d8c91f4c9cf)
BibTeX
@misc{dc117f409e5098,
  title = {Cost-effectiveness of the national dog rabies prevention and control program in Mexico, 1990-2015 — Europe PMC PMID:33661891},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/33661891},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_117f409e5098; sha256 83187543d24a1294a8e4561c05ad8d45df046e81c682f0afd5c22d8c91f4c9cf},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/33661891. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Background: Rabies is a viral zoonosis that imposes a substantial disease and economic burden in many developing countries. Dogs are the primary source of rabies transmission; eliminating dog rabies reduces the risk of exposure in humans significantly. Through mass annual dog rabies vaccination campaigns, the national program of rabies control in Mexico progressively reduced rabies cases in dogs and humans since 1990. In 2019, the World Health Organization validated Mexico for eliminating rabies as a public health problem. Using a governmental perspective, we retrospectively assessed the economic costs, effectiveness, and cost-effectiveness of the national program of rabies control in Mexico, 1990-2015. Methodology: Combining various data sources, including administrative records, national statistics, and scientific literature, we retrospectively compared the current scenario of annual dog vaccination campaigns and post-exposure prophylaxis (PEP) with a counterfactual scenario without an annual dog vaccination campaign but including PEP. The counterfactual scenario was estimated using a mathematical model of dog rabies transmission (RabiesEcon). We performed a thorough sensitivity analysis of the main results. Principal findings: Results suggest that in 1990 through 2015, the national dog rabies vaccination program in Mexico prevented about 13,000 human rabies deaths, at an incremental cost (MXN 2015) of $4,700 million (USD 300 million). We estimated an average cost of $360,000 (USD 23,000) per human rabies death averted, $6,500 (USD 410) per additional year-of-life, and $3,000 (USD 190) per dog rabies death averted. Results were robust to several counterfactual scenarios, including high and low rabies transmission scenarios and various assumptions about potential costs without mass dog rabies vaccination campaigns. Conclusions: Annual dog rabies vaccination campaigns have eliminated the transmission of dog-to-dog rabies and dog-mediated human rabies deaths in Mexico. According to World Health Organization standards, our results show that the national program of rabies control in Mexico has been highly cost-effective.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera).
Pubblicazione: PLoS neglected tropical diseases, 2021 (prima pubblicazione 2021-03-04).
Identificativi: PMID 33661891 · PMCID PMC7963054 · DOI 10.1371/journal.pntd.0009130.
Descrittori MeSH principali: Cost-Benefit Analysis.
Pagina: https://europepmc.org/article/MED/33661891 — https://doi.org/10.1371/journal.pntd.0009130. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0.
Letto il 2026-11-05T15:59:44.435Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.